Gene-centric Association Mapping of Chromosome 3p Implicates MST1 in IBD Pathogenesis

Overview

Journal Mucosal Immunol

Publisher Elsevier

Specialty Allergy & Immunology

Date 2008 Dec 17

PMID 19079170

Citations 38

Authors

P Goyette

C Lefebvre

A Ng

S R Brant

J H Cho

R H Duerr

M S Silverberg

K D Taylor

A Latiano

G Aumais

C Deslandres

G Jobin

V Annese

M J Daly

R J Xavier

J D Rioux

Affiliations

Soon will be listed here.

Abstract

Association mapping and candidate gene studies within inflammatory bowel diseases (IBD) linkage regions, as well as genome-wide association studies in Crohn's disease (CD) have led to the discovery of multiple risk genes, but these explain only a fraction of the genetic susceptibility observed in IBD. We have thus been pursuing a region on chromosome 3p21-22 showing linkage to CD and ulcerative colitis (UC) using a gene-centric association mapping approach. We identified 12 functional candidate genes by searching for literature cocitations with relevant keywords and for gene expression patterns consistent with immune/intestinal function. We then performed an association study composed of a screening phase, where tagging single nucleotide polymorphisms (SNPs) were evaluated in 1,020 IBD patients, and an independent replication phase in 745 IBD patients. These analyses identified and replicated significant association with IBD for four SNPs within a 1.2 Mb linkage disequilibrium region. We then identified a non-synonymous coding variant (rs3197999, R689C) in the macrophage-stimulating 1 (MST1) gene (P-value 3.62 x 10(-6)) that accounts for the association signal, and shows association with both CD and UC. MST1 encodes macrophage-stimulating protein (MSP), a protein regulating the innate immune responses to bacterial ligands. R689C is predicted to interfere with MSP binding to its receptor, suggesting a role for this gene in the pathogenesis of IBD.

Citing Articles

Identification of potential novel targets for treating inflammatory bowel disease using Mendelian randomization analysis.

Fan J, Lu Y, Gan J, Lu H Int J Colorectal Dis. 2024; 39(1):165.

PMID: 39414629 PMC: 11485038. DOI: 10.1007/s00384-024-04744-2.

Polymorphism rs3197999 in Pediatric Patients with Inflammatory Bowel Disease.

Brylak J, Nowak J, Dybska E, Glapa-Nowak A, Kierkus J, Osiecki M Medicina (Kaunas). 2024; 60(8).

PMID: 39202524 PMC: 11356727. DOI: 10.3390/medicina60081243.

Genetic vulnerability to Crohn's disease reveals a spatially resolved epithelial restitution program.

Nakata T, Li C, Mayassi T, Lin H, Ghosh K, Segerstolpe A Sci Transl Med. 2023; 15(719):eadg5252.

PMID: 37878672 PMC: 10798370. DOI: 10.1126/scitranslmed.adg5252.

An Introduction and Overview of RON Receptor Tyrosine Kinase Signaling.

Hunt B, Fox L, Davis J, Jones A, Lu Z, Waltz S Genes (Basel). 2023; 14(2).

PMID: 36833444 PMC: 9956929. DOI: 10.3390/genes14020517.

Harnessing formal concepts of biological mechanism to analyze human disease.

Darden L, Kundu K, Pal L, Moult J PLoS Comput Biol. 2018; 14(12):e1006540.

PMID: 30586388 PMC: 6306204. DOI: 10.1371/journal.pcbi.1006540.

References

Liu Q, Fruit K, Ward J, Correll P . Negative regulation of macrophage activation in response to IFN-gamma and lipopolysaccharide by the STK/RON receptor tyrosine kinase. J Immunol. 1999; 163(12):6606-13. View

Omata F, Birkenbach M, Matsuzaki S, Christ A, Blumberg R . The expression of IL-12 p40 and its homologue, Epstein-Barr virus-induced gene 3, in inflammatory bowel disease. Inflamm Bowel Dis. 2001; 7(3):215-20. DOI: 10.1097/00054725-200108000-00006. View

Ogura Y, Bonen D, Inohara N, Nicolae D, Chen F, Ramos R . A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001; 411(6837):603-6. DOI: 10.1038/35079114. View

Kimura H, Miura S, Shigematsu T, Ohkubo N, Tsuzuki Y, Kurose I . Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig Dis Sci. 1997; 42(5):1047-54. DOI: 10.1023/a:1018849405922. View

Chen Y, Fisher J, Wang M . Activation of the RON receptor tyrosine kinase inhibits inducible nitric oxide synthase (iNOS) expression by murine peritoneal exudate macrophages: phosphatidylinositol-3 kinase is required for RON-mediated inhibition of iNOS expression. J Immunol. 1998; 161(9):4950-9. View

Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K . A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet. 2007; 39(2):207-11. DOI: 10.1038/ng1954. View

Hugot J, Chamaillard M, Zouali H, Lesage S, Cezard J, Belaiche J . Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001; 411(6837):599-603. DOI: 10.1038/35079107. View

Rioux J, Xavier R, Taylor K, Silverberg M, Goyette P, Huett A . Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. 2007; 39(5):596-604. PMC: 2757939. DOI: 10.1038/ng2032. View

Carafoli F, Chirgadze D, Blundell T, Gherardi E . Crystal structure of the beta-chain of human hepatocyte growth factor-like/macrophage stimulating protein. FEBS J. 2005; 272(22):5799-807. DOI: 10.1111/j.1742-4658.2005.04968.x. View

10.

Binder V . Genetic epidemiology in inflammatory bowel disease. Dig Dis. 1999; 16(6):351-5. DOI: 10.1159/000016891. View

11.

Barrett J, Fry B, Maller J, Daly M . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2004; 21(2):263-5. DOI: 10.1093/bioinformatics/bth457. View

12.

Leonard E, Skeel A . Isolation of macrophage stimulating protein (MSP) from human serum. Exp Cell Res. 1978; 114(1):117-26. DOI: 10.1016/0014-4827(78)90043-5. View

13.

Schreiber S, Nikolaus S, Hampe J . Activation of nuclear factor kappa B inflammatory bowel disease. Gut. 1998; 42(4):477-84. PMC: 1727068. DOI: 10.1136/gut.42.4.477. View

14.

Tello-Ruiz M, Curley C, DelMonte T, Giallourakis C, Kirby A, Miller K . Haplotype-based association analysis of 56 functional candidate genes in the IBD6 locus on chromosome 19. Eur J Hum Genet. 2006; 14(6):780-90. DOI: 10.1038/sj.ejhg.5201612. View

15.

Kullberg M, Jankovic D, Feng C, Hue S, Gorelick P, McKenzie B . IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med. 2006; 203(11):2485-94. PMC: 2118119. DOI: 10.1084/jem.20061082. View

16.

Smith P, Ochsenbauer-Jambor C, Smythies L . Intestinal macrophages: unique effector cells of the innate immune system. Immunol Rev. 2005; 206:149-59. DOI: 10.1111/j.0105-2896.2005.00288.x. View

17.

Kirchhofer D, Yao X, Peek M, Eigenbrot C, Lipari M, Billeci K . Structural and functional basis of the serine protease-like hepatocyte growth factor beta-chain in Met binding and signaling. J Biol Chem. 2004; 279(38):39915-24. DOI: 10.1074/jbc.M404795200. View

18.

Paavola P, Helio T, Kiuru M, Halme L, Turunen U, Terwilliger J . Genetic analysis in Finnish families with inflammatory bowel disease supports linkage to chromosome 3p21. Eur J Hum Genet. 2001; 9(5):328-34. DOI: 10.1038/sj.ejhg.5200626. View

19.

Waltz S, Eaton L, Hess K, Peace B, Ihlendorf J, Wang M . Ron-mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses. J Clin Invest. 2001; 108(4):567-76. PMC: 209396. DOI: 10.1172/JCI11881. View

20.

Iwama A, Wang M, Yamaguchi N, Ohno N, Okano K, Sudo T . Terminal differentiation of murine resident peritoneal macrophages is characterized by expression of the STK protein tyrosine kinase, a receptor for macrophage-stimulating protein. Blood. 1995; 86(9):3394-403. View